021-51111890
购物车（0）
sales@molnova.cn
Azalanstat
CAS No. 143393-27-5
Azalanstat ( —— )
产品货号. M34054 CAS No. 143393-27-5
Azalanstat (RS 21607) is an orally available selective mammalian lanosterol 14-alpha-demethylase inhibitor with hypocholesterolemic activity that inhibits cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes, and hamster livers through inhibition of the cytochrome P450 enzyme, lanosterol 14 alpha demethylase.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | ￥11886 | 有现货 |
|
| 50MG | ￥15484 | 有现货 |
|
| 100MG | ￥19125 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Azalanstat
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Azalanstat (RS 21607) is an orally available selective mammalian lanosterol 14-alpha-demethylase inhibitor with hypocholesterolemic activity that inhibits cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes, and hamster livers through inhibition of the cytochrome P450 enzyme, lanosterol 14 alpha demethylase.
-
产品描述Azalanstat (RS 21607) is an orally available selective mammalian lanosterol 14-alpha-demethylase inhibitor with hypocholesterolemic activity that inhibits cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes, and hamster livers through inhibition of the cytochrome P450 enzyme, lanosterol 14 alpha demethylase.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点P450
-
受体P450
-
研究领域——
-
适应症——
化学信息
-
CAS Number143393-27-5
-
分子量429.96
-
分子式C22H24ClN3O2S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC([C@]1(CCC2=CC=C(Cl)C=C2)O[C@H](CSC3=CC=C(N)C=C3)CO1)N4C=CN=C4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Furafylline
Furafylline 是人细胞色素 P450 (CYP)1A2 的选择性抑制剂 (IC50 : 0.07 μM)，
-
Diosmetin
地奥司丁是一种 O-甲基化黄酮，是一种可以在高加索野豌豆中发现的化合物。
-
CYP1B1-IN-7
CYP1B1-IN-7 is a selective and potent CYP1B1 inhibitor showing cytotoxic effects in docetaxel-resistant CYP1B1 overexpressing MCF-7 cell lines, and can be used in synergistic treatment of cancer with anticancer compounds.
